Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Tatsch

Showing results (21-30 of 139) with videos related to

Pageof 14
Sort By:
European Journal of Nuclear Medicine|December 1, 1994
Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinomaC M Kirsch, J von Pawel, I Grau, et al.
Nuklearmedizin. Nuclear Medicine|June 6, 2007
Equipment-independent reference values for dopamine transporter imaging with 123I-FP-CITW Koch, J Hornung, C Hamann, et al.
Nuclear Medicine Communications|August 1, 1991
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's diseaseK Tatsch, J Schwarz, W H Oertel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonismP E Radau, R Linke, P J Slomka, et al.
Nuclear Medicine Communications|December 29, 2000
Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?A Tausig, P Knesewitsch, K Brinkbäumer, et al.
Neurology|January 1, 1994
Cerebral involvement in McLeod syndromeA Danek, I Uttner, T Vogl, et al.
Psychiatry Research|October 1, 1998
Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?J Schwarz, J Scherer, C Trenkwalder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapyJ Schwarz, K Tatsch, T Gasser, et al.
Deutsche Medizinische Wochenschrift (1946)|September 25, 2008
[Selective internal radiotherapy for advanced liver tumors and metastases]R-T Hoffmann, T F Jakobs, K Tatsch, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 19, 2005
Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET studyM Soyka, W Koch, H J Möller, et al.
Pageof 14

Showing results (21-30 of 139) with videos related to

Sort By:
Pageof 14
European Journal of Nuclear Medicine|December 1, 1994
Indium-111 pentetreotide in the diagnostic work-up of patients with bronchogenic carcinomaC M Kirsch, J von Pawel, I Grau, et al.
Nuklearmedizin. Nuclear Medicine|June 6, 2007
Equipment-independent reference values for dopamine transporter imaging with 123I-FP-CITW Koch, J Hornung, C Hamann, et al.
Nuclear Medicine Communications|August 1, 1991
SPECT imaging of dopamine D2 receptors with 123I-IBZM: initial experience in controls and patients with Parkinson's syndrome and Wilson's diseaseK Tatsch, J Schwarz, W H Oertel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 25, 2000
Optimization of automated quantification of 123I-IBZM uptake in the striatum applied to parkinsonismP E Radau, R Linke, P J Slomka, et al.
Nuclear Medicine Communications|December 29, 2000
Is a low-dose Tc-99m-MIBI protocol suitable for first-pass RNV?A Tausig, P Knesewitsch, K Brinkbäumer, et al.
Neurology|January 1, 1994
Cerebral involvement in McLeod syndromeA Danek, I Uttner, T Vogl, et al.
Psychiatry Research|October 1, 1998
Reduced striatal dopaminergic innervation shown by IPT and SPECT in patients under neuroleptic treatment: need for levodopa therapy?J Schwarz, J Scherer, C Trenkwalder, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 1997
[123]IBZM binding predicts dopaminergic responsiveness in patients with parkinsonism and previous dopaminomimetic therapyJ Schwarz, K Tatsch, T Gasser, et al.
Deutsche Medizinische Wochenschrift (1946)|September 25, 2008
[Selective internal radiotherapy for advanced liver tumors and metastases]R-T Hoffmann, T F Jakobs, K Tatsch, et al.
European Archives of Psychiatry and Clinical Neuroscience|April 19, 2005
Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients. Results from a FDG-PET studyM Soyka, W Koch, H J Möller, et al.
Pageof 14